CD8A and neoplasm: Compared to other formulations, Lip-DOPE-P5-MPL induced a higher level of IFN-γ production in CD8+ lymphocytes, more effectively inhibited tumor growth in the TUBO tumor mouse model, and significantly prolonged survival time [95].